Inactive Instrument
Argos Therapeutics Inc Stock Nasdaq
Stocks
US0402211033
Pharmaceuticals
OTC Markets Traded| Market Cap | 318K 283K 262K 237K 447K 29.97M 452K 3.14M 1.23M 15.75M 1.19M 1.17M 50.2M | P/E 2016 |
-2.96x | P/E 2017 | -0.22x |
|---|---|---|---|---|---|
| Enterprise Value | 4.58M 4.09M 3.78M 3.42M 6.45M 433M 6.53M 45.35M 17.8M 227M 17.2M 16.84M 725M | EV / Sales 2016 |
200x | EV / Sales 2017 | 9.19x |
| Free-Float |
88.73% | Yield 2016 * |
-
| Yield 2017 | - |
| 1 day | +0.46% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.46% | +1,231.29% | - | - | 567K | |
| +3.63% | +4.91% | +61.62% | +127.71% | 1,133B | |
| +2.85% | +4.28% | +36.89% | +74.47% | 621B | |
| +0.10% | +0.35% | +24.36% | +96.50% | 503B | |
| -0.41% | +2.74% | +39.07% | +64.22% | 379B | |
| +1.96% | +5.44% | +74.74% | +48.13% | 370B | |
| +1.92% | +2.53% | +23.10% | +52.76% | 292B | |
| +2.45% | +1.50% | +2.78% | +27.60% | 262B | |
| +2.27% | +3.22% | +51.36% | +64.06% | 237B | |
| +1.59% | -0.85% | +28.46% | +101.17% | 190B | |
| Average | +1.68% | +3.22% | +38.04% | +72.96% | 443.11B | |
| Weighted average by Cap. | +2.14% | +3.73% | +43.26% | +84.94% |
| 2016 | 2017 | |
|---|---|---|
| Net sales | 945K 843K 780K 706K 1.33M 89.22M 1.35M 9.35M 3.67M 46.9M 3.55M 3.47M 149M | 1.9M 1.69M 1.57M 1.42M 2.67M 179M 2.7M 18.79M 7.37M 94.21M 7.13M 6.98M 300M |
| Net income | -53.03M -47.25M -43.75M -39.59M -74.59M -5B -75.47M -525M -206M -2.63B -199M -195M -8.38B | -40.58M -36.16M -33.48M -30.3M -57.08M -3.83B -57.75M -401M -157M -2.01B -152M -149M -6.41B |
| Net Debt | -13.11M -11.68M -10.81M -9.79M -18.44M -1.24B -18.66M -130M -50.88M -650M -49.17M -48.15M -2.07B | 4.27M 3.8M 3.52M 3.19M 6M 403M 6.07M 42.21M 16.56M 212M 16.01M 15.67M 675M |
Employees
-
Sector
Pharmaceuticals
